These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 28906438)

  • 1. Acetylcholinesterase and Nicotinic Acetylcholine Receptors in Schistosomes and Other Parasitic Helminths.
    You H; Liu C; Du X; McManus DP
    Molecules; 2017 Sep; 22(9):. PubMed ID: 28906438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Journey to Discovering a Flatworm Target of Praziquantel: A Long TRP.
    Park SK; Marchant JS
    Trends Parasitol; 2020 Feb; 36(2):182-194. PubMed ID: 31787521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition or knockdown of ABC transporters enhances susceptibility of adult and juvenile schistosomes to Praziquantel.
    Kasinathan RS; Sharma LK; Cunningham C; Webb TR; Greenberg RM
    PLoS Negl Trop Dis; 2014 Oct; 8(10):e3265. PubMed ID: 25330312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolomics reveal alterations in arachidonic acid metabolism in Schistosoma mekongi after exposure to praziquantel.
    Chienwichai P; Tipthara P; Tarning J; Limpanont Y; Chusongsang P; Chusongsang Y; Adisakwattana P; Reamtong O
    PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009706. PubMed ID: 34473691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schistosomiasis chemotherapy.
    Thétiot-Laurent SA; Boissier J; Robert A; Meunier B
    Angew Chem Int Ed Engl; 2013 Jul; 52(31):7936-56. PubMed ID: 23813602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of schistosomiasis on host vaccine responses.
    Nono JK; Kamdem SD; Musaigwa F; Nnaji CA; Brombacher F
    Trends Parasitol; 2022 Jan; 38(1):67-79. PubMed ID: 34389214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of praziquantel action at a parasitic flatworm ion channel.
    Park SK; Friedrich L; Yahya NA; Rohr CM; Chulkov EG; Maillard D; Rippmann F; Spangenberg T; Marchant JS
    Sci Transl Med; 2021 Dec; 13(625):eabj5832. PubMed ID: 34936384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological Considerations for
    Driciru E; Koopman JPR; Cose S; Siddiqui AA; Yazdanbakhsh M; Elliott AM; Roestenberg M
    Front Immunol; 2021; 12():635985. PubMed ID: 33746974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anthelmintic drug praziquantel activates a schistosome transient receptor potential channel.
    Park SK; Gunaratne GS; Chulkov EG; Moehring F; McCusker P; Dosa PI; Chan JD; Stucky CL; Marchant JS
    J Biol Chem; 2019 Dec; 294(49):18873-18880. PubMed ID: 31653697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis.
    Doenhoff MJ; Cioli D; Utzinger J
    Curr Opin Infect Dis; 2008 Dec; 21(6):659-67. PubMed ID: 18978535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Efflux Pumps in Schistosoma mansoni Praziquantel Resistant Phenotype.
    Pinto-Almeida A; Mendes T; Armada A; Belo S; Carrilho E; Viveiros M; Afonso A
    PLoS One; 2015; 10(10):e0140147. PubMed ID: 26445012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Praziquantel for the treatment of schistosomiasis: its use for control in areas with endemic disease and prospects for drug resistance.
    Doenhoff MJ; Pica-Mattoccia L
    Expert Rev Anti Infect Ther; 2006 Apr; 4(2):199-210. PubMed ID: 16597202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Still hope for schistosomiasis vaccine.
    Ricciardi A; Ndao M
    Hum Vaccin Immunother; 2015; 11(10):2504-8. PubMed ID: 26176659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional characterisation of Schistosoma japonicum acetylcholinesterase.
    You H; Gobert GN; Du X; Pali G; Cai P; Jones MK; McManus DP
    Parasit Vectors; 2016 Jun; 9(1):328. PubMed ID: 27283196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical pharmacology of schistosome TRPA1-like ion channels.
    Bais S; Berry CT; Liu X; Ruthel G; Freedman BD; Greenberg RM
    PLoS Negl Trop Dis; 2018 May; 12(5):e0006495. PubMed ID: 29746471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlling schistosomiasis with praziquantel: How much longer without a viable alternative?
    Bergquist R; Utzinger J; Keiser J
    Infect Dis Poverty; 2017 Mar; 6(1):74. PubMed ID: 28351414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Granulomatous Inflammation and Prophylactic Treatment of Schistosomiasis with a Combination of Edelfosine and Praziquantel.
    Yepes E; Varela-M RE; López-Abán J; Rojas-Caraballo J; Muro A; Mollinedo F
    PLoS Negl Trop Dis; 2015; 9(7):e0003893. PubMed ID: 26191954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schistosome TRP channels: An appraisal.
    Bais S; Greenberg RM
    Int J Parasitol Drugs Drug Resist; 2020 Aug; 13():1-7. PubMed ID: 32250774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis in schistosomes: toward novel targets for the treatment of schistosomiasis.
    Lee EF; Young ND; Lim NT; Gasser RB; Fairlie WD
    Trends Parasitol; 2014 Feb; 30(2):75-84. PubMed ID: 24393571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Praziquantel for Schistosomiasis: Single-Drug Metabolism Revisited, Mode of Action, and Resistance.
    Vale N; Gouveia MJ; Rinaldi G; Brindley PJ; Gärtner F; Correia da Costa JM
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.